# Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

> **NCT06308952** · PHASE4 · RECRUITING · sponsor: **Duan Chuanzhi** · enrollment: 354 (estimated)

## Conditions studied

- Cerebrovascular Event
- Stent Stenosis
- Ischemic Stroke
- Hemorrhagic Stroke
- Stent Thrombosis
- Death, Brain
- Endothelial Dysfunction

## Interventions

- **DRUG:** Atorvastatin 20mg

## Key facts

- **NCT ID:** NCT06308952
- **Lead sponsor:** Duan Chuanzhi
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 354 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- Shenzhen Second People's Hospital
- First Affiliated Hospital of Harbin Medical University
- ZhuHai Hospital
- First Hospital of Shijiazhuang City
- Eighth Affiliated Hospital, Sun Yat-sen University
- First Affiliated Hospital of Jinan University
- Dongguan Kanghua Hospital
- Beijing Tiantan Hospital
- Guangdong 999 Brain Hospital
- The First Affiliated Hospital of Zhengzhou University
- First Affiliated Hospital of Chongqing Medical University
- Dongguan People's Hospital
- Xinqiao Hospital of Chongqing
- Shanxi Cardiovascular Hospital
- Peking Union Medical College Hospital
- Tianjin Huanhu Hospital

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06308952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06308952, "Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT06308952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*